Clinical trial
Bupropion as a Smoking Cessation Aid in Alcoholics
NCT00044434 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00044434 |
|---|---|
| Title | Bupropion as a Smoking Cessation Aid in Alcoholics |
| Official title | Bupropion as a Smoking Cessation Aid in Alcoholics |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism, Smoking |
| Intervention type | Drug |
| Interventions | bupropion (Wellbutrin) |
| Enrollment | 200 |
| Start date | May 1, 2002 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Aug 30, 2002 |
| Last update posted | Jan 29, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: